Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017;18(3):256.
doi: 10.2174/1389450117999151116144835.

Editorial: Targets for Immunotherapy in Acute Leukemia

Christopher S Hourigan  1
Affiliations
Editorial

Editorial: Targets for Immunotherapy in Acute Leukemia

Christopher S Hourigan. Curr Drug Targets. 2017.
No abstract available

PubMed Disclaimer

Comment on

  • Curr Drug Targets.

References

    1. Hourigan CS, Levitsky HI. Evaluation of current cancer immunotherapy: hemato-oncology. Cancer J 2011; 17(5): 309–24. - PMC - PubMed
    1. Fry TJ, Mackall CL. T-cell adoptive immunotherapy for acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2013: p. 348–53. - PMC - PubMed
    1. Kochenderfer JN, Rosenberg SA. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol 2013; 10(5): 267–76. - PMC - PubMed
    1. Goswami M, Hourigan CS. Novel antigen targets for immunotherapy of acute myeloid leukemia. Curr Drug Targets 2017; 18(3): 296–303. - PMC - PubMed
    1. Cruz CR, Bollard C. Adoptive immunotherapy for leukemia with ex vivo expanded T cells. Curr Drug Targets 2017; 18(3): 271–80. - PMC - PubMed

Publication types

MeSH terms

Substances